Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Aptose Biosciences Q2 2024 GAAP EPS $(0.43) Beats $(0.86) Estimate

Author: Benzinga Newsdesk | August 08, 2024 05:51pm

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.86) by 50 percent.

Posted In: APTO